On November 18, 2016, the Board of Directors of HH Biotechnology Holdings company adopted resolutions increasing the number of directors on the board to five and electing Mr. Charles T. Mathews as a director to fill the new directorship and Mr. Mathews was assigned as the chairman of the Compensation Committees of the Board of Directors of the company.